GSK plc Files 6-K for Q1 Results
Ticker: GSK · Form: 6-K · Filed: Apr 29, 2026 · CIK: 0001131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GSK) |
| Form Type | 6-K |
| Filed Date | Apr 29, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: results, financials, disclosure
TL;DR
GSK dropped Q1 results 4/29, check the 6-K.
AI Summary
GSK plc filed a 6-K report on April 29, 2026, disclosing its first quarter results. The filing includes the complete submission text file and details the company's mailing and business addresses in London, United Kingdom.
Why It Matters
This filing provides investors with the latest financial performance data for GSK plc for the first quarter of 2026.
Risk Assessment
Risk Level: low — This is a routine financial disclosure filing with no immediate new risks identified.
Key Players & Entities
- GSK plc (company) — Filer of the 6-K report
- 0001131399 (company) — CIK number for GSK plc
- 2026-04-29 (date) — Filing date and period of report
FAQ
What type of report is this 6-K filing?
This is a Report of foreign issuer, filed under Rules 13a-16 and 15d-16.
When was this filing accepted by the SEC?
The filing was accepted on April 29, 2026, at 08:09:42.
What is the CIK number for GSK plc?
The CIK number for GSK plc is 0001131399.
What is the SIC code listed for GSK plc?
The SIC code listed is 2834, which corresponds to Pharmaceutical Preparations.
What document type is associated with the first quarter results?
The document type for the first quarter results is a 6-K.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 29, 2026 regarding GSK plc (GSK).